Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Nuvo Pharmaceuticals Inc (MRV.TO)

Nuvo Pharmaceuticals Inc (MRV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 15,374
  • Shares Outstanding, K 11,388
  • Annual Sales, $ 68,907 K
  • Annual Income, $ -32,205 K
  • 60-Month Beta 0.92
  • Price/Sales 0.49
  • Price/Cash Flow 2.26
  • Price/Book 1.81
Trade MRV.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.07
  • Most Recent Earnings $0.00 on N/A
  • Latest Earnings Date 03/27/23
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.30 +3.85%
on 02/21/23
1.35 unch
on 03/15/23
+0.04 (+3.05%)
since 02/14/23
3-Month
0.66 +104.55%
on 12/19/22
1.35 unch
on 03/15/23
+0.69 (+104.55%)
since 12/14/22
52-Week
0.50 +170.00%
on 06/27/22
1.55 -12.90%
on 03/24/22
+0.04 (+3.05%)
since 03/15/22

Most Recent Stories

More News
Jobs Figures Due Friday in U.S.

Monday U.S. Featured Earnings Jefferies Financial Group Inc. (NYSE:JEF) (Q1) EPS estimates ...

LAS-A.TO : 145.82 (+1.25%)
MRV.TO : 1.35 (unch)
DLCG.TO : 3.00 (unch)
JEF : 43.22 (+0.37%)
SAIC : 128.96 (+0.20%)
PROG : 0.8845 (-3.47%)
MU : 109.70 (-2.89%)
LULU : 354.40 (-1.72%)
MKC : 74.55 (-1.99%)
PAYX : 119.41 (+0.51%)
AER : 85.52 (+1.22%)
WBA : 17.34 (-2.20%)
Stocks in play: Nuvo Pharmaceuticals Inc

Announced it has been named to the 2022 OTCQX® Best 50, a ranking of top performing companies traded ...

MRV.TO : 1.35 (unch)
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021

LOS ANGELES, CA / ACCESSWIRE / December 6, 2021 / The SNN Network Canada Virtual Event will take place on December 7-9, 2021, where 70 SmallCap, MicroCap and NanoCap public and private companies will be...

AKR.VN : 0.095 (+5.56%)
AKRFF : 0.0610 (-14.69%)
ADCO.TO : 0.2450 (unch)
ADCOF : 0.1818 (+13.55%)
ACT.CN : 1.3700 (-2.14%)
ACTHF : 1.0100 (-0.57%)
ACOG.VN : 0.240 (unch)
ACOGF : 0.4800 (+1.05%)
ALY.VN : 0.070 (-6.67%)
ATIXF : 0.0581 (-5.07%)
AQS.VN : 0.010 (-33.33%)
AQSZF : 0.0094 (-25.98%)
Miravo Healthcare(TM) to Present at the SNN Network Canada Virtual Event on Wednesday, December 8, 2021

MISSISSAUGA, ON / ACCESSWIRE / November 25, 2021 / Nuvo Pharmaceuticals Inc. (TSX:MRV)(OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused healthcare company with global reach...

MRV.TO : 1.35 (unch)
MRVFF : 0.9795 (+0.46%)
Stocks in play: Nuvo Pharmaceuticals Inc.

Will be presenting at the SNN Network Canada Virtual Event 2021 on Wednesday, December 8 at 11:00 a.m. ...

MRV.TO : 1.35 (unch)
Miravo Healthcareâ„¢ Announces Third Quarter 2021 Results

Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products,...

MRV.TO : 1.35 (unch)
MRVFF : 0.9795 (+0.46%)
Miravo Healthcareâ„¢ Announces Third Quarter 2021 Results Release Date and Conference Call Details

Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products,...

MRV.TO : 1.35 (unch)
MRVFF : 0.9795 (+0.46%)
Keynotes, Educational Panels and 66 Companies to Present at the Planet MicroCap Showcase: VIRTUAL on April 20-22, 2021

LOS ANGELES, CA / ACCESSWIRE / April 19, 2021 / The Planet MicroCap Showcase will take place on April 20-22, 2021, where 66 SmallCap, MicroCap and NanoCap public and private companies will be presenting...

ADGS : 0.1750 (-4.89%)
IOM.VN : 5.400 (-7.69%)
ARHH : 7.6500 (-4.38%)
BNXA.VN : 0.650 (+3.17%)
BNXAF : 0.4572 (+0.44%)
BAMM.CN : 0.0950 (-13.64%)
BMMJ : 0.0727 (-14.77%)
CRGE : 0.0210 (-30.92%)
CTHR : 0.3560 (+6.81%)
CTS.TO : 5.26 (-1.68%)
CTSDF : 3.8000 (-2.86%)
DN.TO : 0.0300 (unch)
Miravo Healthcare(TM) to Present at the Planet MicroCap Showcase: VIRTUAL on Thursday, April 22, 2021 at 10:00 a.m. EST

MISSISSAUGA, ON / ACCESSWIRE / April 12, 2021 / Nuvo Pharmaceuticals® Inc. (TSX:MRV)(OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused healthcare company with global reach...

MRV.TO : 1.35 (unch)
MRVFF : 0.9795 (+0.46%)
Miravo Healthcare to present at the Q1 Virtual Investor Summit

MISSISSAUGA, Ontario, March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare™ today announced that Jesse Ledger, President...

MRV.TO : 1.35 (unch)
MRVFF : 0.9795 (+0.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Nuvo Pharmaceuticals Inc doing business as Miravo Healthcare which is a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license...

See More

Key Turning Points

3rd Resistance Point 1.36
2nd Resistance Point 1.36
1st Resistance Point 1.35
Last Price 1.35
1st Support Level 1.34
2nd Support Level 1.34
3rd Support Level 1.33

See More

52-Week High 1.55
Last Price 1.35
Fibonacci 61.8% 1.15
Fibonacci 50% 1.02
Fibonacci 38.2% 0.90
52-Week Low 0.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar